Cargando…

Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats

OBJECTIVE: Multiple clinical and preclinical studies have reported a signal intensity increase and the presence of gadolinium (Gd) in the brain after repeated administration of Gd-based contrast agents (GBCAs). This bioanalytical study in rat brain tissue was initiated to investigate whether the res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frenzel, Thomas, Apte, Chirag, Jost, Gregor, Schöckel, Laura, Lohrke, Jessica, Pietsch, Hubertus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464750/ https://www.ncbi.nlm.nih.gov/pubmed/28125438 http://dx.doi.org/10.1097/RLI.0000000000000352

Ejemplares similares

Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents
por: Lohrke, Jessica, et al.
Publicado: (2017)

Impact of brain tumors and radiotherapy on the presence of gadolinium in the brain after repeated administration of gadolinium-based contrast agents: an experimental study in rats
por: Jost, Gregor, et al.
Publicado: (2019)

Gadolinium Accumulation in the Deep Cerebellar Nuclei and Globus Pallidus After Exposure to Linear but Not Macrocyclic Gadolinium-Based Contrast Agents in a Retrospective Pig Study With High Similarity to Clinical Conditions
por: Boyken, Janina, et al.
Publicado: (2018)

Signal Increase on Unenhanced T1-Weighted Images in the Rat Brain After Repeated, Extended Doses of Gadolinium-Based Contrast Agents: Comparison of Linear and Macrocyclic Agents
por: Jost, Gregor, et al.
Publicado: (2016)

Penetration and distribution of gadolinium-based contrast agents into the cerebrospinal fluid in healthy rats: a potential pathway of entry into the brain tissue
por: Jost, Gregor, et al.
Publicado: (2016)

Preclinical Profile of Gadoquatrane: A Novel Tetrameric, Macrocyclic High Relaxivity Gadolinium-Based Contrast Agent
por: Lohrke, Jessica, et al.
Publicado: (2022)

The Effect of Gadolinium-Based Contrast Agents on Longitudinal Changes of Magnetic Resonance Imaging Signal Intensities and Relaxation Times in the Aging Rat Brain
por: Green, Claudia, et al.
Publicado: (2022)

Gadolinium Retention in the Brain of Mother and Pup Mouse: Effect of Pregnancy and Repeated Administration of Gadolinium‐Based Contrast Agents
por: Yao, Xiang, et al.
Publicado: (2022)

Gadolinium deposition in the brain of dogs after multiple intravenous administrations of linear gadolinium based contrast agents
por: Richter, Henning, et al.
Publicado: (2020)

Gadolinium retention within multiple rat organs after intra-articular administration of gadolinium-based contrast agents
por: Ringler, Michael D., et al.
Publicado: (2021)

Gadolinium contrast agents: Over exposure?
por: Biederman, Robert W, et al.
Publicado: (2016)

Impact of Treatment With Chelating Agents Depends on the Stability of Administered GBCAs: A Comparative Study in Rats
por: Boyken, Janina, et al.
Publicado: (2019)

Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats
por: Robert, Philippe, et al.
Publicado: (2016)

Gadolinium-DTPA: A New Contrast Agent
por: Niendorf, H. P.
Publicado: (1988)

Investigation of potential adverse central nervous system effects after long term oral administration of gadolinium in mice
por: Nörenberg, Dominik, et al.
Publicado: (2020)

Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration
por: Davies, Julie, et al.
Publicado: (2022)

Comprehensive phenotyping revealed transient startle response reduction and histopathological gadolinium localization to perineuronal nets after gadodiamide administration in rats
por: Habermeyer, Johanna, et al.
Publicado: (2020)

Methodological Aspects for Preclinical Evaluation of Gadolinium Presence in Brain Tissue: Critical Appraisal and Suggestions for Harmonization—A Joint Initiative
por: Robert, Philippe, et al.
Publicado: (2018)

Differences in gadolinium retention after repeated injections of macrocyclic MR contrast agents to rats
por: Bussi, Simona, et al.
Publicado: (2017)

The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review
por: Olchowy, Cyprian, et al.
Publicado: (2017)

Gadolinium Complexes as Contrast Agent for Cellular NMR Spectroscopy
por: Sakol, Nat, et al.
Publicado: (2020)

Fibromyalgia associated with repeated gadolinium contrast-enhanced MRI examinations
por: Lattanzio, Silvia Maria, et al.
Publicado: (2020)

T(1) Shortening in the Cerebral Cortex after Multiple Administrations of Gadolinium-based Contrast Agents
por: Khant, Zaw Aung, et al.
Publicado: (2016)

Gadolinium retention and clearance after administration of macrocyclic magnetic resonance contrast agents to rats
por: Bussi, Simona, et al.
Publicado: (2019)

The Impact of Injector-Based Contrast Agent Administration on Bolus Shape and Magnetic Resonance Angiography Image Quality
por: Jost, Gregor, et al.
Publicado: (2017)

Biocompatible Polyhydroxyethylaspartamide-based Micelles with Gadolinium for MRI Contrast Agents
por: Jeong, Sang Young, et al.
Publicado: (2010)

Immediate reaction to gadolinium based contrast agent with fatal outcome()()()
por: Behzadi, Ashkan Heshmatzadeh, et al.
Publicado: (2018)

Gadolinium-Based Contrast Agents Hypersensitivity: A Case Series
por: Nucera, Eleonora, et al.
Publicado: (2021)

Gadolinium-based contrast agents in neurofibromatosis type 1 (Review)
por: Năstase, Florentina, et al.
Publicado: (2021)

Recent Advances in Gadolinium Based Contrast Agents for Bioimaging Applications
por: Fatima, Atiya, et al.
Publicado: (2021)

Changes in Urinary and Serum Levels of Novel Biomarkers after Administration of Gadolinium-based Contrast Agents
por: Mawad, Habib, et al.
Publicado: (2016)

Acute respiratory distress syndrome following administration of gadolinium contrast agent: a case report
por: Osawa, Eduardo Atsushi, et al.
Publicado: (2022)

Analytical Interference in Serum Iron Determination Reveals Iron Versus Gadolinium Transmetallation With Linear Gadolinium-Based Contrast Agents
por: Fretellier, Nathalie, et al.
Publicado: (2014)

Hypersensitivity to Gadolinium-Based Contrast Media
por: Gracia Bara, M. Teresa, et al.
Publicado: (2022)

Fatal Allergic Reaction to Gadolinium Contrast
por: Chalise, Som N, et al.
Publicado: (2023)

Renal Safety of Repeated Intravascular Administrations of Iodinated or Gadolinium-Based Contrast Media within a Short Interval
por: Kwon, Chiheon, et al.
Publicado: (2021)

Thermal Excitation of Gadolinium-Based Contrast Agents Using Spin Resonance
por: Dinger, Steven C., et al.
Publicado: (2016)

Acute respiratory distress syndrome after the use of gadolinium contrast agent
por: Kerget, Bugra, et al.
Publicado: (2018)

The New Restrictions on the Use of Linear Gadolinium-based Contrast Agents in Japan
por: Kanda, Tomonori
Publicado: (2018)

Effect of different doses of gadolinium contrast agent on clinical outcomes in MS
por: Ackermans, Nathalie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l09rrre9rlcln923lddoaus18d